New York · Series A–Late Stage · 79 people tracked
Also known as BLACKSTONE ALTERNATIVE ASSET MANAGEMENT L.P. · BLACKSTONE ALTERNATIVE CREDIT ADVISORS LP · BLACKSTONE ALTERNATIVE INVESTMENT ADVISORS LLC · BLACKSTONE ALTERNATIVE SOLUTIONS L.L.C. · BLACKSTONE ASSET BASED FINANCE ADVISORS LP · BLACKSTONE CLO MANAGEMENT LLC (MANAGEMENT SERIES) · BLACKSTONE CREDIT BDC ADVISORS LLC · BLACKSTONE CREDIT SYSTEMATIC STRATEGIES LLC · BLACKSTONE EUROPE FUND MANAGEMENT S.A.R.L. · BLACKSTONE GROWTH ADVISORS L.L.C. · BLACKSTONE INFRASTRUCTURE ADVISORS L.L.C. · BLACKSTONE IRELAND FUND MANAGEMENT LIMITED · BLACKSTONE IRELAND LIMITED · BLACKSTONE ISG-I ADVISORS L.L.C. · BLACKSTONE ISG-II ADVISORS L.L.C. · BLACKSTONE LIQUID CREDIT ADVISORS I LLC · BLACKSTONE LIQUID CREDIT STRATEGIES LLC · BLACKSTONE MANAGEMENT PARTNERS L.L.C. · BLACKSTONE MULTI-ASSET ADVISORS L.L.C. · BLACKSTONE PRIVATE CREDIT STRATEGIES LLC · BLACKSTONE PRIVATE INVESTMENTS ADVISORS L.L.C. · BLACKSTONE PROPERTY ADVISORS L.P. · BLACKSTONE REAL ESTATE ADVISORS EUROPE L.P. · BLACKSTONE REAL ESTATE ADVISORS L.P. · BLACKSTONE REAL ESTATE ADVISORS V L.P. · BLACKSTONE REAL ESTATE SPECIAL SITUATIONS ADVISORS L.L.C. · BLACKSTONE STRATEGIC ALLIANCE ADVISORS L.L.C. · BLACKSTONE STRATEGIC CAPITAL ADVISORS, L.L.C. · BLACKSTONE TACTICAL OPPORTUNITIES ADVISORS L.L.C. · BX REIT ADVISORS L.L.C. · BXMT ADVISORS L.L.C. · CLARUS VENTURES, LLC · CLOVER CREDIT MANAGEMENT, LLC · CT INVESTMENT MANAGEMENT CO., LLC · HARVEST FUND ADVISORS LLC · STRATEGIC PARTNERS FUND SOLUTIONS ADVISORS L.P.
Find your way into Blackstone Life Sciences
727 people in our graph can introduce you to the Blackstone Life Sciences team.
Sign up to see every warm intro you have to Blackstone Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Blackstone Life Sciences team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
BXLS aims to bring vital medicines and technologies to market by designing, funding and executing clinical trials for products generally in late-stage development. It seeks to fill a funding void in the life sciences industry by collaborating with leading pharmaceutical, biotechnology and medical technology companies to advance their critical-path products to patients. BXLS combines clinical, commercial and operational expertise with Blackstone's global network, capital access and infrastructure to select, fund and advance promising products and companies. Its strategy targets attractive, largely market- and interest-rate-uncorrelated returns at lower risk by capturing value directly from the products it funds rather than from equity exposure.
Source: firm website, verified Sep 29, 2026.
Team · 79 people
from the firm's website & curated & public directoriesFounder mafia
The Blackstone Life Sciences mafia →59 people who came through Blackstone Life Sciences went on to found or lead other companies.
What they invest in
from 16 of 20 portfolio companiesBiotech ×7SaaS ×6Healthtech ×5Medical Devices ×4Enterprise Software ×3Fintech ×2InsurTech ×2Marketplaces ×2
HQs:United States×6
Investments · 20 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 12024 · 12020 · 22019 · 12016 · 19 dated
Alnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.
BiotechDigital HealthMedical DevicesCambridge, US
John Maraganore(Founder)inPhillip Sharp(Founder)David Bartel(Founder)Thomas Tuschl(Founder)Paul Schimmel(Founder)Phillip Zamore(Founder)
Co-investorsARCH Venture PartnersAtlas VentureCardinal PartnersInvivo Capital PartnersAlexandria
Apogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.
BiotechHealthtechMedical Devices
Michael Henderson(Chief Executive Officer and Director)in
Co-investorsAccess BiotechnologyRA CapitalWellington ManagementPerceptive Xontogeny VentureRTW Investments L.P.Venrock Healthcare Capital Partners
AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.
BiotechLongevityMedical Devices
Andrew Schiermeier(Chief Executive Officer)in
Co-investorsNovo HoldingsEight Roads VenturesF-Prime CapitalNYBC Ventures
Anagram provides insurance administration and revenue cycle management software and billing services for eye care practices, covering eligibility and benefits verification, claim submission and scrubbing, denial management, and payment reconciliation across both vision and medical insurance.
HealthtechInsurTechSaaS
Co-investorsFundersClubWaterline VenturesHealthy VenturesKEC VenturesKickstartNextView Ventures
Anagram builds software to help eye care providers manage vision insurance, lab ordering, and administrative workflows so they can deliver better patient care affordably.
Enterprise SoftwareHealthtechInsurTechSaaS
Austin Winfield(Founder)in
Co-investorsGreatPoint VenturesHealthy VenturesManchesterStory Group, LLCKEC VenturesKickstartNextView Ventures+1 more
Anagram describes itself as an institution focused on crypto and the "ownership economy," offering staking services and deploying human and financial capital in the space.
Crypto & Web3
Austin Winfield(Founder)in
Co-investorsMarin Digital VenturesHealthy VenturesKEC VenturesKickstartNextView VenturesWaterline Ventures
Annexon Bio develops early complement inhibitors that target C1q, the initiating molecule of the classical complement pathway, to treat autoimmune, neurodegenerative, and ophthalmic diseases.
BiotechHealthtechSo. San Francisco, US
Ben Barres(Scientific Co-Founder)Douglas Love(Founder)inMark L Smith(Executive Officer)Campbell Murray(Director)inThomas Wiggans(Director)Ricky Sun(Director)
Co-investorsBain Capital Life SciencesCorrelation VenturesNew Enterprise Associates (NEA)BlackRockClarus VenturesDeerfield Management Company+2 more
Banner provides a centralized platform that consolidates communications, workflows, and document management for commercial real estate teams across the acquisition and disposition lifecycle, reducing administrative overhead.
MarketplacesPropTechSaaSNew York City, US
Kunal Chaudhary(Founder)inEric Gao(Founder)inMark Murphy(Founder)
Co-investorsAmino CapitalBasis Set VenturesPruVen Capital PartnersSidekick PartnersY CombinatorContrary+2 more
Engine (formerly Hotel Engine) operates a business travel management platform that connects companies with lodging, flights, and car rentals to book and manage trips.
FintechMarketplacesSaaSTravel & Hospitality
Elia(CEO)Elia Wallen(Founder)Petar Besevic(Founder)Simon Spurrier(Founder)
Co-investorsElefundTelescope PartnersEntrepreneur First
Revore builds return and collection systems for reusable packaging and other returnable items, deployed at indoor sites such as offices, airports, universities, hospitals, pharmacies, retail chains, quick-service restaurants, and event arenas.
Circular EconomyCleantechHardware
Co-investorsHeadlineKickstart InnovationBond Capital ManagementBullpen Capitallone pine capital
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsFrazier Life SciencesHighlight CapitalMRL Ventures FundXeraya CapitalAmgen VenturesBlackRock+5 more
LRN provides ethics and compliance software, analytics, and training that help organizations manage policies, employee reporting, codes of conduct, and regulatory compliance programs.
EdTechEnterprise SoftwareSaaS
Dov Seidman(Founder)
Co-investorsInsight Partners
Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
BiotechDeep TechMedical DevicesCambridge, US
Robert Langer(Founder)Noubar Afeyan, Ph.D.(Co-founder and Chairman, Moderna; CEO, Flagship Pioneering)Lorence Kim(Executive Officer)inJames R. Kasinger(Executive Officer)inStephen Hoge(Executive Officer)inDerrick Rossi(Founder)
Co-investorsAglae VenturesFlagship PioneeringFPVKhosla VenturesLingottoPremji Invest+5 more
Mollie provides in-person payment tools for European businesses, including card terminals, mobile and fixed POS terminals, and tap-to-pay apps for iPhone and Android, all managed through a central dashboard.
E-commerceFintechRetail TechSaaS
Adriaan Mol(Founder)in
Co-investorsAlkeon InnovationFelicis VenturesGeneral AtlanticKeen Venture PartnersTCVAlkeon Capital+2 more
Norm Ai builds AI agents that automate legal and compliance tasks for large institutions, along with a verification layer for AI agents and an affiliated AI-native law firm.
AI & Machine LearningEnterprise SoftwareLegalTechNew York, US
John Nay(Founder)inMike Schmidtberger(Chairman and Partner, Norm Law)in
Co-investorsBain Capital VenturesCoatue ManagementCraft VenturesKhosla VenturesBain CapitalBlackstone+11 more
AI company developing a medical search engine used by physicians for clinical decision support.
Daniel Nadler(Founder)inZachary Ziegler(Founder)Daniel Nadler Zachary Ziegler(Founder)Zack Ziegler(Founder)
Co-investorsAlkeon InnovationAmity VenturesAndreessen HorowitzBas1s VenturesBond Capital ManagementBreyer Capital+26 more
Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions
BiotechLouisville, US
Suzanne Ildstad(Executive Officer, Director)Scott Requadt(Executive Officer, Director)Geoff Mackay(Director)Francois Nader(Director)
BoardSandip Agarwala(Director)inMark McDade(Director)in
Co-investorsAisling CapitalKeyhorse CapitalLongitude CapitalQiming Venture Partners USAViking GlobalCitadel+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlnylamAnthos Therapeutics, Inc.
Exits · 3
2 IPOs · 1 acquisitionsAlnylam PharmaceuticalsNASDAQ: ALNYApogee TherapeuticsNASDAQ: APGEImagoacq. by Merck
Portfolio news
latest coverage across their companies
Norm Ai · fintech.global · Jul 8, 2026
Open Evidence · techcrunch.com · Oct 20, 2025
Frequently asked questions
- How many investments has Blackstone Life Sciences made?
- Blackstone Life Sciences has 20 tracked investments, 3 of which have exited, including 5 dated in the last 24 months.
- What stage does Blackstone Life Sciences invest at?
- Blackstone Life Sciences invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What is Blackstone Life Sciences's typical check size?
- Blackstone Life Sciences typically writes checks of $20M – $60M.
- What sectors does Blackstone Life Sciences focus on?
- Blackstone Life Sciences focuses on AI & Machine Learning, Biotech, Crypto & Web3, Digital Health, Energy, Healthtech, Longevity, Medical Devices, PropTech, Sector Agnostic.
- Where is Blackstone Life Sciences located?
- Blackstone Life Sciences is headquartered in New York, US.
- Who does Blackstone Life Sciences co-invest with?
- Blackstone Life Sciences most often shares deals with ARCH Venture Partners, Atlas Venture, Cardinal Partners, among 15 tracked co-investors.
Images
Similar investors
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Bayern Kapital is a public venture capital and growth investor backing innovative Bavarian high-tech, deep tech and life sciences start-ups and scale-ups, acting as an anchor investor across multiple funding rounds.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.































































































-2.png)













































